Dorsavi (DVL) Short Interest
Dorsavi (ASX:DVL) had 0.01% of shares reported as short positions as of 1 June 2026, representing 124,850 shares. Dorsavi operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Dorsavi
Dorsavi (DVL) specializes in medical research and development, providing advanced wearable sensor technology for medical, sporting, and occupational health and safety applications. Their unique value lies in their revolutionary wireless technology, which accurately and objectively measures and analyzes human movement and muscle activity using patented algorithms, offering quality data without the need for a lab environment.
Short position
Dorsavi (ASX:DVL) has 0.01% of its shares on issue reported as short positions as of 1 June 2026, or about 124,850 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. DVL is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 34, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4DVL intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Dorsavi
Latest DVL news
All news- dorsaVi Completes CMOS Fabrication for RRAM Validation Chip
asx
- dorsaVi Commences Silicon Fabrication of First RRAM-CMOS Validation Chip
smallcaps
- dorsaVi (ASX:DVL) puts the RRAM chip on wafer and the roadmap finally becomes silicon - Stocks Down Under
googlenews
- dorsaVi Commences Fabrication of First RRAM-CMOS Chip
asx
- Quarterly Activities/Appendix 4C Cash Flow Report
asx
About
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss DVL
Start a research thread or post the first pulse update